Filings Radar

SEC 8-K filings, classified by Claude with reasoning. Updated nightly from EDGAR's daily index (~10 PM ET).

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

KKR FS Income Trust

Other material confidence 75% filed 2026-05-21 Item 8.01

This Item 8.01 disclosure reports the Company's net asset value per Class I Share ($29.23 as of April 30, 2026) and aggregate NAV (~$1.582 billion), along with the status of an ongoing private offering ($1.667 billion raised to date of a $5.0 billion target). While NAV reporting is routine for closed-end funds, the disclosure of offering progress and valuation metrics would be material to investors evaluating the fund's performance and capital-raising trajectory. This does not fit neatly into the more specific event categories (not earnings, M&A, impairment, litigation, etc.), so other_material is most appropriate.

View raw filing on EDGAR →

KKR FS Income Trust Select

Dilutive issuance confidence 95% filed 2026-05-21 Item 3.02

The Company issued 195,291.294 Class I shares for approximately $4.894 million in an unregistered private offering relying on Section 4(a)(2) of the Securities Act and Regulation D. This is a classic dilutive equity issuance to accredited investors outside registered channels, which is material to existing shareholders as it increases share count and dilutes ownership.

View raw filing on EDGAR →

RELIANCE, INC.

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This is a clear Item 5.07 disclosure of shareholder vote results from Reliance, Inc.'s Annual Meeting of Stockholders held on May 20, 2026. The filing reports voting outcomes on four matters: election of nine directors, advisory approval of named executive officer compensation, ratification of KPMG LLP as independent auditor, and a stockholder proposal on director tenure. These are routine but material governance matters that affect investor understanding of board composition and corporate oversight.

View raw filing on EDGAR →

CNH Equipment Trust 2026-B

M&A activity confidence 75% filed 2026-05-21 Item 1.01

CNH Capital Receivables LLC is entering into material definitive agreements (Underwriting Agreement and Trust Agreement) in connection with a $907.68 million asset-backed securitization issuance by CNH Equipment Trust 2026-B. While this is technically a financing/capital markets transaction rather than a traditional M&A activity, the magnitude and nature of the transaction—involving entry into multiple material definitive agreements that restructure the registrant's capital structure—falls within the scope of Item 1.01 material definitive agreements. The transaction would materially affect a reasonable investor's assessment of the registrant's financial position and obligations.

View raw filing on EDGAR →

CNH Equipment Trust 2026-B

Other material confidence 65% filed 2026-05-21 Item 8.01

The filing discloses a public issuance of Notes by a Trust in connection with the Registrant, with supporting agreements and CEO certifications required under Form SF-3. While the prose does not explicitly state the offering amount or closing details, the reference to a prospectus-governed public debt issuance and regulatory certifications indicates a material financing event. However, the Item 8.01 classification and lack of explicit M&A or capital structure language prevent confident assignment to a more specific category.

View raw filing on EDGAR →

SIERRA BANCORP

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This is a clear disclosure of shareholder vote results from Sierra Bancorp's annual meeting held May 20, 2026. The filing reports voting outcomes on three proposals: election of directors (with detailed vote tallies for each nominee), ratification of Forvis Mazars, LLP as independent auditor (98.23% approval), and advisory vote on executive compensation (96.38% approval). The detailed vote counts and percentages are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.

View raw filing on EDGAR →

FUELCELL ENERGY INC

Exec appointment confidence 92% filed 2026-05-21 Item 5.02

The disclosure centers on the election and appointment of John Livingston as a new director effective May 19, 2026, with concurrent appointments to the Audit, Finance and Risk Committee and Compensation and Leadership Development Committee. While compensatory details are provided (annual retainer of $50,000, committee fees, and 5,896 RSUs), the principal disclosed action is the director taking office, making this an exec_appointment event. The appointment of a new board member is material to investors as it affects board composition and governance.

View raw filing on EDGAR →

FUELCELL ENERGY INC

Exec appointment confidence 95% filed 2026-05-21 Item 7.01

The filing discloses the election of John Livingston to the Board of Directors via press release on May 21, 2026. This is a director appointment, which is a material executive change that would affect a reasonable investor's assessment of the company's governance and leadership composition.

View raw filing on EDGAR →

NRG ENERGY, INC.

Exec appointment confidence 95% filed 2026-05-21 Item 5.02

The Board appointed Glenn Wright as an independent director effective May 26, 2026, and assigned him to the Finance and Risk Management Committee. This is a clear executive appointment of a director with relevant energy industry experience (former Shell executive). Director appointments are material to investors as they affect board composition and governance.

View raw filing on EDGAR →

COGNITION THERAPEUTICS INC

Other material confidence 72% filed 2026-05-21 Item 8.01

The disclosure announces completion of an FDA meeting regarding zervimesine for dementia with Lewy bodies patients with psychosis. This represents a material regulatory milestone for a clinical-stage biopharmaceutical company, but does not fit neatly into more specific categories (not an earnings release, M&A activity, or litigation). FDA meeting outcomes can materially affect development timelines and investor expectations for drug candidates.

View raw filing on EDGAR →

Rigetti Computing, Inc.

Dilutive issuance confidence 85% filed 2026-05-21 Item 3.02

Item 3.02 discloses an unregistered sale of equity securities by Rigetti Computing in reliance on Section 4(a)(2) and/or Regulation D exemptions. The filing explicitly references a private offering of securities, which is a classic dilutive issuance event material to investors assessing ownership dilution and capital structure changes.

View raw filing on EDGAR →

Rigetti Computing, Inc.

Other material confidence 65% filed 2026-05-21 Item 7.01

The filing discloses entry into a Letter of Intent by Rigetti's wholly-owned subsidiary, which typically signals a potential material acquisition or transaction. However, the Item 7.01 disclosure is deliberately non-binding ("furnished" under Regulation FD, not "filed"), and the specific nature of the transaction is not detailed in the excerpt provided. Without clarity on whether this is an acquisition, disposition, or other transaction type, and given the preliminary nature of a LOI, this is best classified as other_material rather than ma_activity, which typically applies to more definitive agreements or completed transactions.

View raw filing on EDGAR →

Rigetti Computing, Inc.

Other material confidence 75% filed 2026-05-21 Item 8.01

Rigetti entered into a non-binding letter of intent with the U.S. Department of Commerce for a $100 million CHIPS and Science Act award over three years, contingent on negotiating definitive agreements and involving issuance of common stock to the Department at a discounted price. While this represents a material government funding opportunity and contemplates a dilutive equity issuance, the LOI is explicitly non-binding and preliminary, making it difficult to classify as a definitive M&A activity or dilutive issuance. The event is material to investors due to the significant funding amount and equity dilution implications, but does not fit cleanly into the more specific categories.

View raw filing on EDGAR →

S&P Global Inc.

M&A activity confidence 92% filed 2026-05-21 Item 8.01

S&P Global's Board approved the separation of its Mobility division through a pro rata distribution of 100% of Mobility Global shares to shareholders, with an effective date of July 1, 2026. This constitutes a material change of control and disposition event—the company is divesting a major business unit and spinning it off as an independent public company. While technically a "spin-off" rather than a traditional M&A transaction, it represents a fundamental restructuring that materially affects the registrant's asset base and shareholder value, falling squarely within the ma_activity category.

View raw filing on EDGAR →

Mayville Engineering Company, Inc.

Dilutive issuance confidence 95% filed 2026-05-21 Item 1.01

Mayville Engineering entered into an underwriting agreement on May 19, 2026 to issue 4,348,000 shares of common stock at $20.00 per share, with an additional 652,000 shares from a fully exercised option, generating approximately $93.9 million in net proceeds. This is a material registered public offering of equity securities that dilutes existing shareholders and is a significant capital-raising event for the company.

View raw filing on EDGAR →

Mayville Engineering Company, Inc.

Dilutive issuance confidence 85% filed 2026-05-21 Item 7.01

The disclosure announces the launch and pricing of an offering on May 19, 2026, with press releases filed as exhibits. While the Item 7.01 designation and Regulation FD language suggest this is a disclosure-only filing, the substance—announcement of an offering launch and pricing—indicates a dilutive equity issuance. This is material to investors as it signals capital raising and potential shareholder dilution.

View raw filing on EDGAR →

DEERE JOHN CAPITAL CORP

Earnings release confidence 95% filed 2026-05-21 Item 2.02

This is a disclosure of quarterly and year-to-date financial results for John Deere Capital Corporation, including revenue, net income, and ending portfolio balance for Q2 and first six months of fiscal 2026 compared to 2025. The filing presents key financial metrics and explains drivers of performance (favorable financing spreads, lower provision for credit losses, favorable derivative valuations), which is characteristic of an earnings release under Item 2.02.

View raw filing on EDGAR →

DEERE JOHN CAPITAL CORP

Earnings release confidence 95% filed 2026-05-21 Item 7.01

The filing discloses Deere & Company's (the parent of JDCC) press release announcing second quarter fiscal 2026 results of operations, with supporting presentation materials furnished as exhibits. This is a classic earnings release disclosure, material to investors assessing the registrant's financial performance and condition.

View raw filing on EDGAR →

DEERE JOHN CAPITAL CORP

Earnings release confidence 85% filed 2026-05-21 Item 8.01

Item 8.01 incorporates by reference the disclosure in Item 2.02, which is the standard Item for earnings releases. The cross-reference indicates that financial results are being disclosed and incorporated into Other Events, making this an earnings release event that would be material to investors assessing the registrant's financial performance.

View raw filing on EDGAR →

AVALONBAY COMMUNITIES INC

M&A activity confidence 99% filed 2026-05-21 Item 1.01

This Item 1.01 discloses entry into a definitive merger agreement between AvalonBay Communities and Equity Residential in an all-stock "merger-of-equals" transaction with an exchange ratio of 2.793 Equity Residential shares per AvalonBay share. The filing describes the material acquisition/combination of two major REITs, including governance arrangements, equity award conversions, and closing conditions—all hallmarks of a material M&A transaction requiring Item 1.01 disclosure.

View raw filing on EDGAR →

AVALONBAY COMMUNITIES INC

M&A activity confidence 95% filed 2026-05-21 Item 7.01

AvalonBay entered into a Merger Agreement with Equity Residential, as announced via joint press release on May 21, 2026. This constitutes a material acquisition/change of control event. Although disclosed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 1.01, the substance is unmistakably a merger transaction that would materially affect a reasonable investor's assessment of the company.

View raw filing on EDGAR →

Barinthus Biotherapeutics plc.

Shareholder vote confidence 95% filed 2026-05-21 Item 5.07

This Item 5.07 filing discloses the results of two shareholder votes held on May 20, 2026: a Court Meeting of Scheme Shares and a General Meeting of shareholders, both approving a Scheme of Arrangement (a merger/acquisition transaction). The overwhelming approval rates (99.98% in favor at both meetings) and the explicit statement that "All matters submitted to a vote of the Company's stockholders...were approved" directly match the shareholder_vote_results event type. This is material as it represents shareholder approval of a significant corporate transaction.

View raw filing on EDGAR →

NANOVIRICIDES, INC.

Other material confidence 72% filed 2026-05-21 Item 7.01

The disclosure reveals material clinical development information about NanoViricides' drug candidates, including that NV-387 is "now entering Phase II clinical trial against Mpox in DRC" and that the company has developed an oral formulation of remdesivir encapsulated in NV-387 nanoviricide micelles with demonstrated efficacy in animal models. The company also states it has "a clinical site in DRC for treatment of Mpox patients." This represents significant clinical progress and pipeline advancement that would affect a reasonable investor's assessment of the company's development stage and commercial prospects, but does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, impairment, or litigation).

View raw filing on EDGAR →

DEERE & CO

Earnings release confidence 99% filed 2026-05-21 Item 2.02

The filing discloses Deere & Company's second quarter fiscal 2026 results of operations via a press release furnished as Exhibit 99.1 under Item 2.02. This is a standard earnings release announcement, which is material to investors as it provides quarterly financial performance and is a core disclosure required for public companies.

View raw filing on EDGAR →

DEERE & CO

Earnings release confidence 85% filed 2026-05-21 Item 7.01

The filing discloses a presentation reviewing second quarter fiscal 2026 results made available in connection with an investor earnings call on May 21, 2026. Although filed under Item 7.01 (Regulation FD Disclosure) rather than Item 2.02, the substance is an earnings release—the company is furnishing quarterly financial results to investors via presentation. This is material to investors assessing the registrant's financial performance.

View raw filing on EDGAR →

SPS COMMERCE INC

Exec departure confidence 92% filed 2026-05-21 Item 5.02

Kimberly Nelson, the former Executive Vice President and Chief Financial Officer, is retiring effective June 1, 2026. Although the filing also mentions Joseph Del Preto's prior appointment as her successor (March 16, 2026), the principal disclosed action in this Item 5.02 section is Ms. Nelson's departure—the determination of her retirement date and the waiver of the six-month notice requirement to allow her equity awards to be treated under retirement provisions. The departure of a CFO is material to investors.

View raw filing on EDGAR →

NOCOPI TECHNOLOGIES INC/MD/

M&A activity confidence 95% filed 2026-05-21 Item 1.01

The filing discloses entry into a material asset purchase agreement on May 18, 2026, whereby Nocopi Technologies' subsidiary acquired substantially all assets of Polymeric U.S., Inc.'s business for $2.65 million in aggregate consideration (cash, assumed liabilities, and 500,000 common shares). This is a material acquisition transaction completed on the signing date, directly falling under Item 1.01 and the ma_activity category. The transaction also includes concurrent private placement financing of 266,668 shares at $1.50/share to fund the acquisition.

View raw filing on EDGAR →

NOCOPI TECHNOLOGIES INC/MD/

M&A activity confidence 95% filed 2026-05-21 Item 2.01

Item 2.01 explicitly discloses completion of an acquisition or disposition of assets under an Asset Purchase Agreement. The filing references Item 1.01 (entry into the agreement) and Item 2.01 (completion), indicating a material M&A transaction has been consummated. This is a core material event affecting the registrant's asset base and financial position.

View raw filing on EDGAR →

NOCOPI TECHNOLOGIES INC/MD/

Dilutive issuance confidence 95% filed 2026-05-21 Item 3.02

The filing discloses unregistered issuance of "Consideration Shares" and "Placement Shares" to accredited investors under Section 4(a)(2) exemption. This is a classic private placement of equity securities that dilutes existing shareholders. The explicit reference to Item 3.02 (Unregistered Sales of Equity) and the detailed disclosure of the exemption basis confirm this is a material dilutive equity issuance.

View raw filing on EDGAR →

NOCOPI TECHNOLOGIES INC/MD/

M&A activity confidence 95% filed 2026-05-21 Item 7.01

The filing discloses the Company's announcement of "the acquisition of the Business" pursuant to an Asset Purchase Agreement, along with a concurrent Private Placement. Although filed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 1.01, the substance is clearly a material acquisition event. The press release explicitly announces both the acquisition and the private placement financing, making this a significant M&A activity that would materially affect a reasonable investor's assessment of the registrant.

View raw filing on EDGAR →

PEABODY ENERGY CORP

Exec departure confidence 95% filed 2026-05-21 Item 5.02

Joe W. Laymon resigned from the Board of Directors effective immediately due to personal health reasons, vacating his committee memberships. This is a clear director departure disclosure under Item 5.02, and board-level departures are material to investors assessing governance and continuity.

View raw filing on EDGAR →

Sphere 3D Corp.

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This is a clear disclosure of shareholder voting results from a Special Meeting of Shareholders held on May 15, 2026, covering five proposals including share issuance, board size, director elections, incentive plan amendments, and share consolidation. The filing directly reports vote tallies (For, Against, Withheld, Broker Non-Votes) for each proposal, which is the defining characteristic of Item 5.07 shareholder_vote_results. The material nature is evident from the proposals' substance—particularly the Share Issuance Proposal approving consideration securities in connection with an "Arrangement" (acquisition), board restructuring, and incentive plan expansion.

View raw filing on EDGAR →

Sphere 3D Corp.

Shareholder vote confidence 92% filed 2026-05-21 Item 7.01

The filing discloses "voting results of the Meeting" via press release on May 21, 2026. This language directly indicates shareholder vote results from an annual or special meeting, which is the defining characteristic of Item 5.07 events. Although disclosed under Item 7.01 (Regulation FD), the substantive content is shareholder voting results, which are material to investors assessing corporate governance and shareholder approval of key matters.

View raw filing on EDGAR →

Starfighters Space, Inc.

Earnings release confidence 95% filed 2026-05-21 Item 2.02

The filing discloses a news release issued on May 20, 2026 reporting financial results for Q1 fiscal year 2026 (period ended March 31, 2026), with the release attached as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02, which is material to investors as it provides periodic financial performance information.

View raw filing on EDGAR →

Starfighters Space, Inc.

Earnings release confidence 92% filed 2026-05-21 Item 7.01

The company issued a news release on May 20, 2026 to report financial results for the first quarter of fiscal year 2026, with the quarterly report and condensed consolidated interim financial statements available on the company's website and SEC EDGAR. This is a standard earnings release disclosure under Regulation FD, even though filed under Item 7.01 rather than the more typical Item 2.02, and is material to investors assessing the registrant's financial performance.

View raw filing on EDGAR →

COGNIZANT TECHNOLOGY SOLUTIONS CORP

Other material confidence 72% filed 2026-05-21 Item 2.03

Cognizant drew $1 billion under its revolving credit facility on May 20, 2026, creating a direct financial obligation under Item 2.03. While this is a material debt incurrence that would affect investor assessment of liquidity and leverage, it does not fit neatly into the more specific event categories (covenant_breach, going_concern, or dilutive_issuance). The filing discloses a routine credit facility draw rather than a breach, distress signal, or equity issuance, making "other_material" the most appropriate classification.

View raw filing on EDGAR →

IDAHO POWER CO

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This is a classic Item 5.07 disclosure of shareholder vote results from IDACORP's 2026 Annual Meeting held on May 21, 2026. The filing reports voting outcomes on three proposals: election of ten directors (all approved), advisory approval of executive compensation (approved), and ratification of Deloitte & Touche LLP as independent auditor (approved). Shareholder meeting results are material to investors as they reflect governance decisions and confirm board composition and auditor appointment.

View raw filing on EDGAR →

AMERICAN TOWER CORP /MA/

Exec Compensation confidence 95% filed 2026-05-21 Item 5.02

The disclosure centers on stockholder approval of the 2026 Equity Incentive Plan on May 20, 2026, which authorizes the issuance of up to 12,000,000 new shares plus additional shares from the Prior Plan for equity-based awards to employees, directors, consultants and advisors. This is a compensatory arrangement disclosure under Item 5.02(e), distinct from executive departures or appointments. The plan's authorization of substantial equity issuance and adoption of RSU and PSU award agreement forms constitute material compensation governance changes.

View raw filing on EDGAR →

AMERICAN TOWER CORP /MA/

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This is a clear disclosure of shareholder voting results from American Tower's Annual Meeting held May 20, 2026. The filing presents final vote tallies for four proposals: (1) election of eleven directors, (2) advisory approval of executive compensation, (3) ratification of Deloitte & Touche LLP as auditor, and (4) approval of the 2026 Equity Incentive Plan. This is a textbook Item 5.07 disclosure of shareholder vote results, which is material to investors as it confirms governance outcomes and compensation/equity plan approvals.

View raw filing on EDGAR →

AMERICAN TOWER CORP /MA/

Other material confidence 65% filed 2026-05-21 Item 8.01

The disclosure announces a cash distribution of $1.79 per share declared by the Board, which is material to shareholders as it affects shareholder returns and cash flow. While dividend announcements are routine for mature REITs like American Tower, the specific per-share amount and payment dates constitute material information affecting investor valuation. This does not fit neatly into the more specific event categories (it is not a restatement, impairment, litigation, or M&A activity), so "other_material" is the appropriate classification.

View raw filing on EDGAR →

Ingredion Inc

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This is a classic Item 5.07 disclosure of shareholder voting results from Ingredion's 2026 annual meeting held on May 20, 2026. The filing reports final vote tallies for three proposals: election of 11 board directors, advisory approval of named executive officer compensation, and ratification of KPMG LLP as independent auditor. The detailed voting results (For/Against/Abstentions/Broker Non-Votes) for each proposal are the core content of the disclosure.

View raw filing on EDGAR →

ONEOK INC /NEW/

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This Item 5.07 disclosure reports the final results of ONEOK's Annual Meeting of Shareholders held on May 20, 2026, covering three proposals: election of ten directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and an advisory vote on executive compensation. The filing presents detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the core content of a shareholder_vote_results event.

View raw filing on EDGAR →

GROUP 1 AUTOMOTIVE INC

Exec appointment confidence 85% filed 2026-05-21 Item 8.01

The disclosure centers on the appointment of Daniel McHenry as President and Chief Executive Officer of Group 1 Automotive U.K., a material executive position. While the filing also mentions Mark Raban's departure, the principal action disclosed is McHenry's appointment to lead a significant operating subsidiary. This is a material executive change that would affect investor assessment of the company's leadership and operations.

View raw filing on EDGAR →

ANI PHARMACEUTICALS INC

Exec Compensation confidence 92% filed 2026-05-21 Item 5.02

The filing discloses stockholder approval of an Amended and Restated 2022 Stock Incentive Plan at the Annual Meeting on May 21, 2026. This is a compensatory arrangement affecting directors and officers, falling squarely within the exec_compensation category. The amendment to a stock incentive plan is material to investors as it affects equity compensation structures and potential dilution.

View raw filing on EDGAR →

ANI PHARMACEUTICALS INC

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This Item 5.07 disclosure presents the complete results of ANI Pharmaceuticals' Annual Meeting of Stockholders, including voting outcomes on director elections, auditor ratification, say-on-pay proposals, and stock plan approval. The detailed vote tallies for all five proposals are the core content, making this a textbook shareholder_vote_results event. The materiality is high because director elections and equity plan approvals directly affect governance and shareholder interests.

View raw filing on EDGAR →

QUEST DIAGNOSTICS INC

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This is a classic Item 5.07 disclosure presenting the voting results from Quest Diagnostics' 2026 Annual Meeting of Stockholders held on May 20, 2026. The filing reports results for four distinct matters: election of 11 directors, advisory approval of executive compensation, ratification of PricewaterhouseCoopers as independent auditor, and a shareholder proposal on independent board chairman. All directors were elected with substantial majorities, compensation was approved, and the auditor was ratified, while the board chairman proposal failed. These results are material to investors assessing governance and board composition.

View raw filing on EDGAR →

VERISIGN INC/CA

Exec Compensation confidence 92% filed 2026-05-21 Item 5.02

The disclosure centers on stockholder approval of an Amendment and Restatement of the VeriSign 2006 Equity Incentive Plan, which is a compensatory arrangement affecting officers and directors. While the amendment does not increase share availability, it extends the plan's termination date to 2036 and revises administrative provisions governing equity awards. This is a material disclosure of a plan amendment subject to shareholder approval, fitting the exec_compensation category under Item 5.02(e).

View raw filing on EDGAR →

VERISIGN INC/CA

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This Item 5.07 disclosure presents the complete voting results from VeriSign's 2026 Annual Meeting of Stockholders across five proposals: election of seven directors, advisory vote on executive compensation, approval of amended equity incentive plan, ratification of KPMG as auditor, and a stockholder proposal on board chairman independence. The detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal are the core content, making this a textbook shareholder vote results disclosure material to investors assessing governance and compensation matters.

View raw filing on EDGAR →

AVIS BUDGET GROUP, INC.

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This is a clear disclosure of shareholder voting results from Avis Budget Group's 2026 Annual Meeting of Shareholders held on May 20, 2026. The filing reports results for four proposals: election of six directors, ratification of Deloitte & Touche LLP as auditors, advisory approval of named executive officer compensation, and a shareholder proposal on governance voting standards. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.

View raw filing on EDGAR →

Texas Community Bancshares, Inc.

Shareholder vote confidence 98% filed 2026-05-21 Item 5.07

This is a clear disclosure of shareholder vote results from the Company's Annual Meeting of Stockholders held on May 19, 2026. The filing reports final voting tallies for two matters: (1) election of three directors (Jason Sobel, Anthony R. Scavuzzo, and Bryan Summerville) and (2) ratification of Forvis Mazars, LLP as independent auditor. This is a routine but material disclosure required under Item 5.07 of Form 8-K.

View raw filing on EDGAR →